Mackenzie Financial’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $905K | Buy |
|
|||||
|
2025
Q1 | $456K | Buy |
|
|||||
|
2024
Q4 | $257K | Buy |
|
|||||
|
2024
Q3 | $17.3K | Sell |
|
|||||
|
2024
Q2 | $30.3K | Buy |
|
|||||
|
2024
Q1 | $45.3K | Buy |
|
|||||
|
2023
Q4 | $28.7K | Buy |
|
|||||
|
2023
Q3 | $17.7K | Sell |
|
|||||
|
2023
Q2 | $24.5K | Sell |
|
|||||
|
2023
Q1 | $23.2K | Sell |
|
|||||
|
2022
Q4 | $39.3K | Hold |
|
|||||
|
2022
Q3 | $22K | Buy |
|
|||||
|
2022
Q2 | $15K | Buy |
|
|||||
|
2022
Q1 | $16K | Buy |
|
|||||
|
2021
Q4 | $48K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $52K | Sell |
|
|||||
|
2020
Q2 | $738K | Sell |
|
|||||
|
2020
Q1 | $770K | Buy |
|
|||||
|
2019
Q4 | $230K | Buy |
|